general inclusion criteria: * be aged 18 and over * have clinical picture strongly suggestive of covid-19-related disease (with/without positive covid-19 test) and * risk count (as defined below) \>3 or * risk count ≥3 if it includes "radiographic severity score \>3" * be hospitalized or eligible for hospitalization on clinical grounds * be considered an appropriate subject for intervention with immunomodulatory or other disease modifying agents in the opinion of the investigator * is able to swallow capsules/tablets general

general inclusion criteria: * be aged 18 and over * have clinical picture strongly suggestive of covid-19-related disease (with/without positive covid-19 test) and * risk count (as defined below) \>3 or * risk count ≥3 if it includes "radiographic severity score \>3" * be hospitalized or eligible for hospitalization on clinical grounds * be considered an appropriate subject for intervention with immunomodulatory or other disease modifying agents in the opinion of the investigator * is able to swallow capsules/tablets general

general inclusion criteria: be aged 18 and over have clinical picture strongly suggestive of covid-19-related disease (with/without positive covid-19 test) and risk count (as defined below) >3 or risk count ≥3 if it includes "radiographic severity score >3" be hospitalized or eligible for hospitalization on clinical grounds be considered an appropriate subject for intervention with immunomodulatory or other disease modifying agents in the opinion of the investigator is able to swallow capsules/tablets general

general inclusion criteria: be aged 18 and over have clinical picture strongly suggestive of covid-19-related disease (with/without positive covid-19 test) and risk count (as defined below) >3 or risk count ≥3 if it includes "radiographic severity score >3" be hospitalized or eligible for hospitalization on clinical grounds be considered an appropriate subject for intervention with immunomodulatory or other disease modifying agents in the opinion of the investigator is able to swallow capsules/tablets general

general inclusion criteria: - be aged 18 and over - have clinical picture strongly suggestive of covid-19-related disease (with/without positive covid-19 test) and - risk count (as defined below) >3 or - risk count ≥3 if it includes "radiographic severity score >3" - be hospitalized or eligible for hospitalization on clinical grounds - be considered an appropriate subject for intervention with immunomodulatory or other disease modifying agents in the opinion of the investigator general

general inclusion criteria: - be aged 18 and over - have clinical picture strongly suggestive of covid-19-related disease (with/without positive covid-19 test) and - risk count (as defined below) >3 or - risk count ≥3 if it includes "radiographic severity score >3" - be hospitalized or eligible for hospitalization on clinical grounds - be considered an appropriate subject for intervention with immunomodulatory or other disease modifying agents in the opinion of the investigator general

general inclusion criteria: - be aged 18 and over - have clinical picture strongly suggestive of covid-19-related disease (with/without positive covid-19 test) and - risk count (as defined below) >3 or - risk count ≥3 if it includes "radiographic severity score >3" - be considered an appropriate subject for intervention with immunomodulatory or other disease modifying agents in the opinion of the investigator general

general inclusion criteria: - be aged 18 and over - have clinical picture strongly suggestive of covid-19-related disease (with/without positive covid-19 test) and - risk count (as defined below) >3 or - risk count ≥3 if it includes "radiographic severity score >3" - be considered an appropriate subject for intervention with immunomodulatory or other disease modifying agents in the opinion of the investigator general